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Abstract On the basis of recent results, we propose a model for 
DNA polymerase translocation along DNA. Human immunode- 
ficiency virus reverse transcriptase is taken as an example. 
According to the model, movement of the enzyme is the result of 
transition of the enzyme-bound DNA from the A- to B-form 
which is accompanied by lengthening of DNA within the binding 
channel. The driving force of this transition is the increase in 
water accessibility to the DNA-binding cleft after dNTP binding. 
dNTP hydrolysis proceeding during the following chemical step 
supplies the energy for the reverse B ~ A transition of DNA. 
Translocation is considered to be an integral part of the stage of 
conformational change preceding catalysis and can be described 
as a worm-like movement of DNA within the DNA-binding cleft. 
Key words: DNA polymerase translocation; HIV reverse 
transcriptase 
1. Introduction 
The progress achieved uring the last decade in studies of 
the enzymes of template catalysis has allowed us to extend our 
understanding of their function on the molecular level. Recent 
investigations revealed striking similarities at the polymerase 
active sites [1-3] and led to generalized models for catalysis 
[1,2,4,5]. Nevertheless, the mechanism by which the DNA 
polymerases translocate along the template chain remains un- 
known [6]. Johnson [7] views translocation as a free diffusion 
of the polymerase along the DNA while in the open state. 
This free linear diffusion is described as an equilibration be- 
tween the n and n+l sites rather than as a distinct rate-limit- 
ing forward step of the polymerase along the DNA. However, 
numerous contacts between the amino acid residues of the 
enzyme and the nucleotides of DNA are observed in the re- 
solved structures of DNA polymerases in opened complexes 
with dsDNA [8,9]. The free sliding model does not explain the 
process of breaking and restoring of these contacts. Patel et al. 
[6] believe that the enzyme moves down the nucleic acid in a 
ratchet-type manner, in 3.4-,~ steps. The energy required for 
the movement of the protein could come from dNTP hydro- 
lysis. In addition, the A- to B-form transitions of dsDNA 
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may also supply some of the energy and dictate the overall 
direction of translocation. However, the authors do not dis- 
cuss details of the mechanism, and its essence remains unclear. 
This mechanism does not explain at which step during the 
polymerization cycle the translocation occurs [6]. Several 
models for RNA polymerase translocation have also been 
proposed [10-15]. 
2. Our model 
The model described below is based on the following ex- 
perimental facts: (1) dsDNA within the binding channel of 
HIV RT is bent, and 6-7 base pairs near the 3'-end of primer 
are in the A-form [8]. Analogous tructure of bound dsDNA 
is found in DNA polymerase 13: the template primer assumes 
an A/B-form hybrid geometry [16]. Chimeric polynucleotides 
containing the regions with both A- and B-forms are known 
to be bent in the junction [17,18]. Therefore, the curved DNA- 
binding cleft is more suitable for accommodating the bent 
DNA. The bending of DNA within the binding channel is a 
common feature of many polymerases [9,19]. Besides, the high 
hydrophobicity of the cleft [20] is also favorable for the B ~ A 
transition [21]. It seems realistic to propose that such a transi- 
tion is a typical phenomenon for DNA polymerases. (2) The 
same 6-7 base pairs near the 3'-end of primer are responsible 
for the specificity of the interaction between template and 
primer within the DNA-binding pocket of the enzyme [22]. 
(3) Many polymerases contain the 'laelix clamp' structure 
which forms non-specific ontacts with the internucleotide 
phosphates of the template primer [23]. In the case of HIV 
RT such a clamp consists of the c~H and (xI helices (Fig. 1) 
which contact he dsDNA at the point of A-B junction [8,23]. 
(4) DNA polymerases from different sources contain a Tyr 
residue near the Y-end of the primer (Tyr-l l5 of HIV-1 RT 
[6] (Fig. 1), Tyr-766 of Klenow fragment [24], Tyr-865 of 
mammalian DNA polymerase c~ [25]). This residue is pro- 
posed to stack with the incoming dNTP [6]. (5) Conforma- 
tional adaptation preceding the chemical stage of nucleotidyl 
transfer is a common step for many DNA polymerases and is 
thought to be responsible for polymerase fidelity [7,26-29]. 
Tryptophan fluorescence quenching studies reveal that this 
stage is accompanied by conformational rearrangement of
the protein which changes from the opened to the closed state 
[7,26]. Another conformational change (the reverse transition) 
takes place after the chemical step [6,7,27]. Moreover, the 
enzyme undergoes conformational changes when dNTP binds 
to the polymerase in the absence of the template primer [30]. 
In this case, as well as upon dNTP binding to the enzyme- 
dsDNA complex, the fluorescence intensity sharply decreases. 
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Fig. 1. Elements of the DNA-binding cleft and the dNTP-binding pocket. Red circles indicate the positions of Mg 2+ ions. Catalytic residues of 
Asp-110, Asp-185, and Asp-186 are shown in green; Tyr-115 is shown in cyan. Incoming dTTP is colored in violet. The primer chain is shown 
in blue, the template chain in yellow. The helix clamp is drawn in white: the left thick white chain indicates the ~I helix; the right thick white 
chain is the ctH helix. The amino acid residues of ctI and the internucleotide phosphates of the template chain, and, analogously, the amino 
acid residues of etH and the internucleotide phosphates of primer chain, which are involved in the formation of contacts between the enzyme 
and DNA before dNTP binding and incorporation [23], are shown as the red regions in these chains. 
This reflects the increase in polarity of the microenvironment 
of the tryptophan residues. This is probably the result of the 
solvent-accessible surface of the enzyme being enlarged ue to 
the translocation of individual subdomains. 
3. Mechanism of translocation 
For HIV RT we propose the following mechanism of trans- 
location. When in the DNA-binding cleft, the template primer 
bends, forms contacts with the helix clamp, and undergoes a 
transition into the A-form in the region between the helix 
clamp and the 3'-end of the primer. Tyr- l l5 is not stacked 
onto the base of the 3'-end nucleotide at this stage (Figs. 1 
and 2A). The triphosphate moiety of incoming dNTP first 
binds to the catalytic triad (Asp-l l0, Asp-185, and Asp- 
186), and its base stacks onto the Tyr- l l5 residue (in accor- 
dance with the model of Patel et al. [6], and with the data of 
Painter et al. [30] on the non-specificity of the initial dNTP 
binding). The bases of the entering dNTP and the Y-end 
nucleotide are 3-4 ,~ apart [6]. dNTP binding leads to a con- 
formational change of the enzyme and to an increase in its 
solvent-accessible surface. The latter leads to the A ~ B tran- 
sition of DNA (increasing the extent of hydration is favorable 
for B-form DNA [21]). Conformational rearrangement of
both the enzyme and DNA should weaken and/or partially 
break the protein-DNA contacts in the clamp. On the other 
hand, the A ~ B transition leads to a 6 ,A extension of a 7 nt 
region of DNA duplex between the helix clamp and the 3'-end 
of the primer (from 18 to 24 ,~) because the distance between 
the neighbouring nucleotides i 2.6 A in A-form, and 3.4 ,A in 
B-form DNA. This lengthening is likely to be a driving force 
moving the 3'-terminal nucleotide up to the base of the dNTP 
bound to the active site and to pull the duplex back 2-3 
along the cleft using Tyr-115 as a fulcrum. Such a mechanism 
allows the simultaneous translocation of DNA and the spatial 
approach of the attacking 3'-OH group of the primer and ct- 
phosphate of dNTP (the latter is the result of the stacking 
between the base of the 3'-terminal nudeotide and the base 
of dNTP) (Fig. 2B). 
The enzyme is able to attain the critical catalytic onfigura- 
tion only if the newly formed base pair can adopt Watson- 
Crick geometry. If the dNTP is incorrect, the closed complex 
is unstable and easily breaks down upon the transition of 
DNA back to the A-form followed by dissociation of 
dNTP. The rapid transesterification step proceeds only after 
the closed state is stabilized. The hydrolysis of the dNTP 
provides the energy for the reverse B ~ A transition of the 
DNA region between the helix clamp and the newly formed 
3'-end of the primer. This transition is thermodynamically 
and kinetically unfavorable in the closed state. The A-DNA 
restores weakened contacts with the helix clamp that leads to 
the conformational switching of the enzyme from the closed 
to the opened state, and the system returns to the starting 
structure, except for the following template position (Fig. 2C). 
4. Crawling DNA 
We would like to emphasize two principal features of the 
model described. First, translocation occurs simultaneously 
with the conformational daptation of the substrate, i.e. it 
occurs before the incorporation of a new dNMP moiety. Sec- 
ond, conformational changes of the protein are not responsi- 
ble for its translocation - instead, DNA 'crawls' along the 
binding cleft by means of lengthening and shortening, like a 
worm moving through the soil. 
This mechanism can explain our earlier findings that the 
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Fig. 2. Stereo diagram of the DNA-binding cleft and the dNTP-binding pocket. Data obtained from the Brookhaven Protein Data Bank (file 
1HM1) were used for preparation of the figure. (A) Initial binding of dTTP. The triphosphate moiety is anchored by three Asp residues; the 
pyrimidine base is stacked with Tyr-115. DNA is in the A-form. (B) The stage of conformational rearrangement. DNA is in the B-form. The 
dTTP base is stacked with the 3'-terminal dA residue and forms the Watson-Crick pair with the dA residue of the template chain. It can be 
seen that the internucleotide phosphates, which were in contact with the helix clamp at the stage of initial binding, slide back and the marked 
residues of helix clamp can form the contacts with new positions of DNA. (C) The state of the system after the incorporation of the dTMP 
moiety. DNA is in the A-form. Red color indicate the sites which were interacting each other in A and became shifted after the incorporation 
of new nucleotide. 
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Vm~x values of DNA polymerization are sufficiently higher for 
many polymerases if ribooligonucleotides (or deoxyribooligo- 
nucleotides with the 3'-terminal ribonucleotide) have been 
used as a primer [31]. The A-like form is preferable for 
RNA-DNA hybrid duplexes [32,33] (and for some short du- 
plexes which contains the ribonucleotide insertion [34]), hence 
the reverse B ~ A transition within the binding channel should 
have a lower energetic barrier in these cases. 
Mikita and Beardsley [35,36] have shown that DNA repli- 
cation can be arrested by structural lesion of arabinosylcyto- 
sine in. the template DNA strand. A striking feature of this 
partial replication block is that it occurs at, rather than be- 
fore, the template lesion site. There appears to be no impedi- 
ment to the addition of the correct nucleotide, dGMP, oppo- 
site araCMP. Most other template lesions result in synthesis 
arrest one nucleotide before the lesion site because of gross 
distortion in the DNA structure and/or loss of the base-coding 
property ([35] and references herein). Structural studies on B- 
form DNA all indicate that the perturbations introduced by 
araC are slight to moderate in their effect, particularly com- 
pared to those changes introduced by many of the more bulky 
modifications of the DNA bases which grossly disturb duplex 
structure and stability. However, its inhibitory effects on 
DNA polymerase can be equal to or greater than some of 
these more aggressive structural lesions [36]. On the other 
hand, a molecular modeling study showed that strong steric 
clashes occurred when araC-G base pairs were built into an 
A-form helix environment [37]. On the basis of our transloca- 
tion model, we could propose that the arabinosylcytosine le- 
sion blocks the reverse transition from the B- to the A-form 
of DNA after the incorporation of a dGMP residue opposite 
the lesion site. As a result, the enzyme cannot restore the 
contacts, which are characteristic of the open state, and read- 
ily dissociates from the template primer. 
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